Novartis AG
DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
Last updated:
Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
Status:
Application
Type:
Utility
Filling date:
20 Sep 2021
Issue date:
12 May 2022